Evidence map›Paper›PMID 26948669›Full record

ArticleEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology2016

Metacognitive impairment in active cocaine use disorder is associated with individual differences in brain structure.

Scott J Moeller, Stephen M Fleming, Gabriela Gan, Anna Zilverstand, Pias Malaker, Federico d'Oleire Uquillas, Kristin E Schneider, Rebecca N Preston-Campbell, Muhammad A Parvaz, Thomas Maloney and 2 more

Open access · greenAbstract read
In one paragraph

Article in European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Neural Correlates of Metacognition Impairment in Opioid Addiction.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Behavioral preference for viewing drugPsychological medicine · 2020
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Scott J MoellerDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Stephen M FlemingWellcome Trust Centre for Neuroimaging, University College London, United Kingdom.
Gabriela GanDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Anna ZilverstandDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Pias MalakerDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Federico d'Oleire UquillasDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Kristin E SchneiderDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Rebecca N Preston-CampbellDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Muhammad A ParvazDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Thomas MaloneyDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Nelly Alia-KleinDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Rita Z GoldsteinDepartments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
Icahn School of Medicine at Mount Sinai · USWellcome Centre for Human Neuroimaging · GB

Funding

Genes, Brain, and Behavior in Human AggressionR01MH090134 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ALIA-KLEIN, NELLY · 2010 to 2014
$3.2M
Machine learning discovery of patterns of self regulation in drug addiction and IR21DA034954 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GOLDSTEIN, RITA Z · 2012 to 2013
$822k
Genetic markers associated with brain structural abnormalities and drug use in human addictionK01DA037452 · NIDA · STATE UNIVERSITY NEW YORK STONY BROOK · PI MOELLER, SCOTT J · 2015 to 2019
$778k
Neurocircuitry of impaired insight in addiction: relevance to aberrant self-related processingR21DA040046 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MOELLER, SCOTT J · 2015 to 2016
$459k
BCI-based feedback system to promote cognitive control of cravingF32DA033088 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI PARVAZ, MUHAMMAD ADEEL · 2012 to 2015
$158k
NIDA NIH HHS F32 DA033088NIDA NIH HHS F32DA033088NIDA NIH HHS K01 DA037452NIDA NIH HHS K01DA037452NIDA NIH HHS R21 DA034954NIDA NIH HHS R21DA034954NIDA NIH HHS R21 DA040046NIDA NIH HHS R21DA040046NIMH NIH HHS R01 MH090134NIMH NIH HHS R01MH090134Wellcome Trust 091593Wellcome Trust WT096185
6 · The paper itself

Abstract

Dysfunctional self-awareness has been posited as a key feature of drug addiction, contributing to compromised control over addictive behaviors. In the present investigation, we showed that, compared with healthy controls (n=13) and even individuals with remitted cocaine use disorder (n=14), individuals with active cocaine use disorder (n=8) exhibited deficits in basic metacognition, defined as a weaker link between objective performance and self-reported confidence of performance on a visuo-perceptual accuracy task. This metacognitive deficit was accompanied by gray matter volume decreases, also most pronounced in individuals with active cocaine use disorder, in the rostral anterior cingulate cortex, a region necessary for this function in health. Our results thus provide a direct unbiased measurement - not relying on long-term memory or multifaceted choice behavior - of metacognition deficits in drug addiction, which are further mapped onto structural deficits in a brain region that subserves metacognitive accuracy in health and self-awareness in drug addiction. Impairments of metacognition could provide a basic mechanism underlying the higher-order self-awareness deficits in addiction, particularly among recent, active users.

Indexed as

MetacognitionAdultAtrophyCase-Control StudiesCocaine-Related DisordersCognition DisordersFemaleGray MatterGyrus CinguliHumansIndividualityMagnetic Resonance ImagingMaleMiddle AgedNeuroimagingNeuropsychological TestsAnterior cingulate cortexDrug addictionMagnetic resonance imagingMetacognitionSelf-awarenessVoxel-based morphometry

Identifiers

PMID26948669
PMCPMC4805109
OpenAlexW2260026916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.